| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.073 | 0.02 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.078 | 0.02 |